BioPharm News

Jun 10, 2010
BioPharm International
In February, we reported on Pfizer's plans for reconfiguring its global manufacturing network of 79 plants, following its recent acquisition of Wyeth. Now, we have the answer.
Jun 10, 2010
BioPharm International
By BioPharm International Editors
Baxter BioScience (Deerfield, IL) and the US Food and Drug Administration have notified healthcare professionals of a market withdrawal being conducted as a precautionary measure because of an increased number of adverse event reports of allergic reactions associated with two lots of GammaGard Liquid.
Jun 09, 2010
By BioPharm International Editors
Xcellerex, Inc. has begun construction of a state-of-the-art current good manufacturing practices-compliant FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA.
Jun 09, 2010
By BioPharm International Editors
Thomson Reuters' Mark Gordon looks at how real partnership opportunities are developing in a virtual pharma world.
Jun 01, 2010
BioPharm International
By BioPharm International Editors
The pharmaceutical and medical device industries can learn from Toyota's recalls to avoid their own "runaway" quality problems.
May 19, 2010
BioPharm International
Now is not an easy time to lead a pharmaceutical company. The patent cliff is fast approaching, pipeline challenges remain, capital markets are tight, and the blockbuster model is fast on its way out. Meanwhile, regulations on sales and marketing continue to tighten.
May 18, 2010
BioPharm International
By BioPharm International Editors
Waters Corporation (Milford, MA) and Ireland's National Institute for Bioprocessing Research and Training (NIBRT, Dublin, Ireland) have formed a collaboration that will create the world?s first database for glycan analysis by UltraPerformance liquid chromatography (UPLC).
May 18, 2010
BioPharm International
By BioPharm International Editors
Ernst & Young has released its annual report on the state of the biotech industry, Beyond Borders: Global Biotechnology Report 2010, and overall, things are looking good for the industry.
May 18, 2010
BioPharm International
By BioPharm International Editors
Delaware-based, iBio, Inc. has been awarded a grant of rights to use its proprietary technology, the iBioLaunch platform, in support of a $5.3 million government-funded project for the development of a single vaccine to protect against both anthrax and plague.
May 18, 2010
BioPharm International
G. Steven Burrill released his 24th annual report on the state of the biotech industry at the BIO International Convention held in Chicago this month. Biotech 2010 -Life Sciences: Adapting for Success provides insight into biotech' s changing environment and how the industry will need to adapt to it.
native1_300x100
lorem ipsum